With nextgeneration sequencing and CART therapy entering the market, the age of precision medicine is upon us. How will individualized treatment revolutionize healthcare as we know it?

Dimensions to be addressed:
Globalizing access and affordability
Redesigning data governance
Navigating ethical complexities

· Nancy Brown, Chief Executive Officer, American Heart Association, USA
· Jay Flatley, Executive Chairman, Illumina, USA
· Scott Gottlieb, Commissioner, United States Food & Drug Administration
· Vasant Narasimhan, Global Head, Drug Development; Chief Executive Officerdesignate, Novartis Pharma, Switzerland
· Tan Chorh Chuan, Executive Director, Office for Healthcare Transformation, Ministry of Health of Singapore

Moderated by
· Linda Pizzuti Henry, Managing Director, Boston Globe, USA

http://www.weforum.org/